Year 2024 in review - chronic pain therapy DOI

J Fricová

Anesteziologie a intenzivní medicína, Journal Year: 2024, Volume and Issue: 35(5), P. 301 - 304

Published: Dec. 19, 2024

Článek přináší výběr zajímavých událostí, jakým byl Světový den bolesti, zejména v návaznosti Evropský který následuje vždy třetí středu říjnu. Vliv Evropské unie na léčbu bolesti aktuálně vydaném dokumentu zmiňuje léky proti nicméně je zájem EU o problematiku chronické zatím spíše okrajový. IASP mezinárodní společnost pro vyhlásila rok 2024 globálním rokem genderových rozdílů bolesti. se snažilo osvětlit toto důležité téma průběhu celosvětového roku a dosáhnout změny přístupu chápání jak u lékařů, tak pacientů. Jak mohou genderové rozdíly interagovat s mechanismy způsobujícími nebo udržujícími bolest, posledních letech oblastí rostoucího zájmu. Nové poznatky byly publikovány kanabidiolu, bude nutná regulace nejen výroby, ale také prodeje reklamy. Aktuálně roce vydán první pokyn klinickou praxi Americké akademie pediatrů (AAP), přístupy založené důkazech k bezpečnému předepisování opioidů akutní bolest pediatrické populace ambulantních zařízeních. Hlavním cílem pomoci lékařům pochopit, kdy být opioidy indikovány léčbě dětí dospívajících minimalizovat rizika užíváním opioidů.

Persistent changes in the dorsal root ganglion nociceptor translatome governs hyperalgesic priming in mice: roles of GPR88 and Meteorin DOI
Ishwarya Sankaranarayanan, Moeno Kume,

Ayaan Mohammed

et al.

Pain, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 28, 2025

Abstract Hyperalgesic priming is a model system that has been widely used to understand plasticity in painful stimulus–detecting sensory neurons, called nociceptors. A key feature of this following priming, stimuli do not normally cause hyperalgesia now readily provoke state. We hypothesized hyperalgesic occurs because reorganization translation mRNA To test hypothesis, we paclitaxel treatment as the stimulus and translating ribosome affinity purification measure persistent changes Na v 1.8+ Translating sequencing revealed 161 genes with persistently altered primed Among these genes, identified Gpr88 upregulated Metrn downregulated. provide functional evidence for related model, interleukin-6 model. GPR88 agonist injection into paw had no effect naive mice but caused mechanical hypersensitivity grimacing responses female mice. Systemic Meteorin completely reversed established prostaglandin E2 Our work demonstrates nociceptor translatomes are causative producing multiple models

Language: Английский

Citations

3

The Effects of Socioeconomic Position on Endogenous Pain Modulation: A Quasi-Experimental Approach DOI
Nandini Raghuraman, Titilola Akintola, Fenan S. Rassu

et al.

Journal of Pain, Journal Year: 2025, Volume and Issue: unknown, P. 104778 - 104778

Published: Jan. 1, 2025

Language: Английский

Citations

0

Emotional Impairments in Animal Models of Traumatic Neuropathic Pain: Where Do We Stand? DOI Creative Commons
Filipa Pinto‐Ribeiro

Biological Psychiatry Global Open Science, Journal Year: 2025, Volume and Issue: 5(1), P. 100424 - 100424

Published: Jan. 1, 2025

Language: Английский

Citations

0

Androgen receptors expressed in the primary sensory neurons regulate mechanical pain sensitivity DOI Open Access
Fumihiro Saika, Daisuke Uta, Yohji Fukazawa

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2025, Volume and Issue: unknown

Published: March 13, 2025

Summary The expression of hormonal receptors in pain-processing regions complicates understanding the effects on pain mechanisms. This study investigates androgen receptor (AR) involvement sensitivity and sex differences perception. Mechanical thresholds were higher normal male mice compared to gonadectomized (GDX) female mice, correlating with serum testosterone levels. In dorsal root ganglia (DRG), AR was expressed males but undetectable GDX females. sensory neuron-selective conditional knockout (AR-cKO) mechanical significantly lower than wild-type males. administration propionate or dihydrotestosterone raised thresholds, accompanied by increased DRG. effect abolished AR-cKO females, consistent findings. These results indicate that primary neurons are critical targets signaling regulating sensitivity.

Language: Английский

Citations

0

A look into the future: Your biological sex may guide chronic pain treatment DOI
Marzia Malcangio, George Sideris-Lampretsas

Neuron, Journal Year: 2025, Volume and Issue: 113(6), P. 800 - 802

Published: March 1, 2025

Language: Английский

Citations

0

How microglia contribute to the induction and maintenance of neuropathic pain DOI
Marzia Malcangio, George Sideris-Lampretsas

Nature reviews. Neuroscience, Journal Year: 2025, Volume and Issue: unknown

Published: March 24, 2025

Language: Английский

Citations

0

Pain kept under wraps of myelin sheath DOI Creative Commons

Veronica I. Shubayev

Frontiers in Pain Research, Journal Year: 2025, Volume and Issue: 6

Published: April 23, 2025

The myelin sheath serves both as insulator and metabolic powerhouse for large-diameter dorsal root ganglia (DRG) neurons—some of the longest cells in body—transmitting sensory impulses from periphery to spinal cord. When is damaged, bioactive fragments basic protein (MBP) are released, playing a pivotal role pathological pain. MBP-derived peptides (MBPd) emerge ubiquitous yet sex-specific mediator In females, MBPd triggers widespread transcriptional response across peripheral nerve, DRG, cord, leading persistent, treatment-resistant tactile allodynia—pain normally innocuous touch. contrast, males exhibit only localized response, confined which does not extend DRG or cord induce sex difference driven by MBPd's interaction with lipids regulation nuclear receptor transcription factors, including estrogen (ESR) liver X (LXR)/retinoid × (RXR) complex—key regulators lipid cholesterol metabolisms mounting sex-dependent immunity. By unraveling these fundamental mechanisms remodeling, this work opens door innovative, non-addictive, personalized therapeutics diagnostics chronic

Language: Английский

Citations

0

Interplay between cannabinoids and the neuroimmune system in migraine DOI Creative Commons
Erik Zorrilla, Adriana Della Pietra, Andrew F. Russo

et al.

The Journal of Headache and Pain, Journal Year: 2024, Volume and Issue: 25(1)

Published: Oct. 15, 2024

Migraine is a common and complex neurological disorder that has high impact on quality of life. Recent advances with drugs target the neuropeptide calcitonin gene-related peptide (CGRP) have helped, but treatment options remain insufficient. CGRP released from trigeminal sensory fibers contributes to peripheral sensitization, perhaps in part due actions immune cells trigeminovascular system. In this review, we will discuss potential cannabinoid targeting as an innovative therapeutic for migraine treatment. We cover endogenous endocannabinoids, plant-derived phytocannabinoids synthetically derived cannabinoids. The focus be six types known express multiple receptors: macrophages, monocytes, mast cells, dendritic B T cells. These also contain receptors such, cannabinoids might potentially modulate efficacy current CGRP-targeting drugs. Unfortunately, date most studies relied cell cultures only single preclinical study tested model. Encouragingly, created stable chiral analog endocannabinoid reduced meningeal degranulation. Likewise, clinical trials evaluating safety cannabinoid-based therapies patients been limited are encouraging. Thus, field at its infancy there significant gaps our understanding migraine. Future research exploring interactions between could lead more targeted effective treatments.

Language: Английский

Citations

3

Multitarget Ligands that Comprise Opioid/Nonopioid Pharmacophores for Pain Management: Current State of the Science DOI Creative Commons
Émile Breault, Michael Desgagné, Jolien De Neve

et al.

Pharmacological Research, Journal Year: 2024, Volume and Issue: unknown, P. 107408 - 107408

Published: Sept. 1, 2024

Language: Английский

Citations

2

The role of androgens in migraine pathophysiology DOI Creative Commons
Adam J. Dourson,

Rachel S. Darken,

Thomas Baranski

et al.

Neurobiology of Pain, Journal Year: 2024, Volume and Issue: 16, P. 100171 - 100171

Published: July 1, 2024

Migraine affects ∼12 % of the worldwide population and is more prevalent in females, which suggests a role sex hormones migraine pathophysiology. Most studies have focused on estrogen progesterone, involvement androgens has been less studied. However, due to recent advances androgen interventions, could advance new androgen-based treatments, it critical better understand migraine. Testosterone, most studied androgen, was found an antinociceptive effect various animal human pain studies. Thus, also protective related lower severity prevalence. In this review, we discuss examining migraine-related symptoms models. Additionally, summarize results comparing levels between patients with healthy controls, assessing relationships severity, intervention impact testosterone treatment severity. Many limitations, however, suggest that may minor Still, possible are involved pathophysiology sub-group such as adolescents or postmenopausal women. We potential mechanisms testosterone, main tested, can These range from cellular level systems behavior include sensory neurons, immune vascular systems, stress response, brain function, mood. Lastly, future directions line research.

Language: Английский

Citations

2